Collegium Pharmaceutical Inc (COLL)

Debt-to-assets ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Long-term debt US$ in thousands
Total assets US$ in thousands 1,663,590 1,635,150 1,053,390 1,114,250 1,143,310 1,177,580 1,213,910 1,214,300 1,174,130 1,200,940 1,245,570 1,246,140 692,077 741,803 713,735 646,065 643,841 643,843 646,870 634,793
Debt-to-assets ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $1,663,590K
= 0.00

Collegium Pharmaceutical Inc has consistently maintained a debt-to-assets ratio of 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt to finance its assets during this period. A debt-to-assets ratio of 0.00 implies that the company's assets are entirely financed by equity, which can be seen as a positive sign of financial stability and strength. It suggests that Collegium Pharmaceutical Inc has a solid financial position with a low level of financial risk associated with debt. Overall, the company's consistent low debt-to-assets ratio reflects a healthy balance sheet structure and prudent financial management.